EssilorLuxottica Total Current Liabilities 2011-2024 | ESLOY

EssilorLuxottica total current liabilities for the quarter ending December 31, 2024 were $11.422B, a 4.48% decline year-over-year.

  • EssilorLuxottica total current liabilities for 2024 were $11.422B, a 8.34% increase from 2023.
  • EssilorLuxottica total current liabilities for 2023 were $10.543B, a 12.58% increase from 2022.
  • EssilorLuxottica total current liabilities for 2022 were $9.364B, a 11.26% decline from 2021.

EssilorLuxottica Total Current Liabilities 2011-2024 | ESLOY

  • EssilorLuxottica total current liabilities for 2024 were $11.422B, a 8.34% increase from 2023.
  • EssilorLuxottica total current liabilities for 2023 were $10.543B, a 12.58% increase from 2022.
  • EssilorLuxottica total current liabilities for 2022 were $9.364B, a 11.26% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$230.9B
Boston Scientific (BSX)$156.3B
Stryker (SYK)$149.6B
Medtronic (MDT)$119B
Lonza Group Ag (LZAGY)$49.8B
Haleon (HLN)$44B
ResMed (RMD)$40.2B
Agilent Technologies (A)$35.7B
GE HealthCare Technologies (GEHC)$33.7B
Terumo (TRUMY)$26.6B
Koninklijke Philips (PHG)$26.6B
Insulet (PODD)$23.9B
Zimmer Biomet Holdings (ZBH)$21B
Smith & Nephew SNATS (SNN)$16.4B
Baxter (BAX)$12.7B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$8.1B
Lantheus Holdings (LNTH)$3.7B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.2B
Haemonetics (HAE)$2.6B
Acuren (TIC)$2.3B
Curaleaf Holdings (CURLF)$2.2B
LeMaitre Vascular (LMAT)$2.2B
QuidelOrtho (QDEL)$1.9B
Green Thumb Industries (GTBIF)$1.8B